Market access and reimbursement in Canada – changes at CADTH

What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health (CADTH) in 2024/2025?

 

Join Clare Foy (Director – Global Market Access, Mtech Access) as she interviews Don Husereau (Adjunct Professor of Medicine, The University of Ottawa) on Friday 22^nd March at 2.00pm (GMT)/10.00am (EDT)/3.00pm (CET) for our next Global Whispers webinar. Register now

In this webinar, we will take a look at the market access, health policy, and health technology assessment in Canada. Clare Foy and Don Husereau will explore:

• The market access landscape in Canada
• Upcoming changes at CADTH
• What Canadian payers expect from your value proposition
• Opportunities and challenges when launching new medicines/medical devices/diagnostics in Canada
• How Canada compares to the USA/key European launch markets
• What this means for your global market access strategy

Learn more about this webinar

Register now

 

More about our speaker

Don Husereau (Adjunct Professor of Medicine, The University of Ottawa)

Don is an Adjunct Professor of Medicine at The University of Ottawa. He is a freelance healthcare researcher, and works with private and public sector life sciences organisations to help them understand the value of health technology and its implications for pricing, reimbursement, and healthcare and innovation policy. In Canada, he has served on National and Provincial Expert appraisal committees and has been an invited expert member of a Federal commission focused on innovation policy. He is also Co-Chair of the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Task Force.

 

We are delighted to welcome Don to the Global Whispers webinar series.

Register now